Myeloma and Related Diseases Registry (MRDR)

The MRDR has reached 5,000 patients registered!!! - an incredible achievement that wouldn't be possible without the support, commitment and great work of participants, site staff and collaborators. Thank you to everyone who has helped make this happen - we look forward to sharing many more milestones with you!

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
5063

Patients accrued

3485

Patients with multiple myeloma

55

Number of approved sites

550

Biobank participants

Latest news

MRFF grant for MRDR MY-PROMPT-2 trial!
11 Jan 2022

MRDR MY-PROMPT-2 project funded!

Read more
5000 patients registered!!
15 Dec 2021

The MRDR reached 5000 registered participants!

Read more
Join us at the Asia-Pacific MRDR Investigators’ meeting!
10 Dec 2021

All are welcome to the Asia-Pacific MRDR Investigators' meeting, Fri, 17 Dec, 4pm AEDT!

Read more
MRDR Investigator meeting VIDEO
23 Sep 2021

Missed it? Want another look? Watch the video here!

Read more

Participating organisations